Author:
Roggel Frigga,Hocke Stefan,Lindemann Kristina,Sinz Sonja,Welk Anita,Bosl Martin,Pabst Martina,Nusser N.,Braun Stephan,Schmitt Manfred,Harbeck Nadia
Publisher
Springer Berlin Heidelberg
Reference66 articles.
1. Allgayer H, Heiss MM, Riesenberg R, Babic R, Jauch KW, Schildberg FW (1997) Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phos-phatase double staining protocol. J Histochem Cytochem 45:203–212
2. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999) Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1:377–388
3. Braun S, Pantel K (1998) Prognostic significance of micrometastatic bone marrow involve-ment. Breast Cancer Res Treat 52:201–216
4. Braun S, Hepp F, Kentenich CR, Janni W, Pantel K, Riethmuller G, Willgeroth F, Sommer HL (1999a) Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 5:3999–4004
5. Braun S, Hepp F, Sommer HL, Pantel K (1999b) Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer 84:1–5
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献